FBRX 株価推移チャート
FBRX 財務
Forte Biosciences Inc
$36.7
78.32%
$16.12
終値： Jul 09, 16:00:00 GMT-4
$37.78
2.94%
$1.07
アフターマーケット：Jul 09, 18:48:50 GMT-4
戻る
Forte Biosciences Inc (FBRX) 財務
主要データ
前終値
$20.58
始値
$21.25
当日レンジ
$21.25 - $37.78
52週レンジ
$9.1 - $37.78
取引高
4.8M
平均取引高
271.3K
配当利回り
--
1株当たり利益(TTM)
-4.58
時価総額
$773.7M
FBRXとは何ですか？
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The company is headquartered in Dallas, Texas and currently employs 19 full-time employees. The company went IPO on 2017-04-13. The company is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The firm's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.
